Sotagliflozin reduces adverse cardiovascular events
Crossref DOI link: https://doi.org/10.1038/s41569-020-00486-0
Published Online: 2020-11-24
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Robson, Andrew
Text and Data Mining valid from 2020-11-24
Version of Record valid from 2020-11-24
Article History
First Online: 24 November 2020